# BUDESONIDE
> **ANDA216667** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-11-29
## Drug
- **FDA Application Number:** ANDA216667
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUDESONIDE
- **Generic name:** BUDESONIDE
- **Active ingredients:** BUDESONIDE
- **Dosage form:** SUSPENSION
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** EUGIA PHARMA
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2023-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216667)
---
*MORVS · CC0 1.0*